[PERSPECTIVES] Genetic Approaches to Facilitate Antibacterial Drug Development

Very few chemically novel agents have been approved for antibacterial chemotherapies during the last 50 yr. Yet new antibacterial drugs are needed to reduce the impact on global health of an increasing number of drug-resistant infections, including highly drug-resistant forms of tuberculosis. This review discusses how genetic approaches can be used to study the mechanism of action of whole-cell screening hits and facilitate target-driven strategies for antimicrobial drug development.

http://perspectivesinmedicine.cshlp.org/cgi/content/short/5/7/a021139?rss=1

Source: Cold Spring Harbor perspectives in medicine - July 1, 2015 Category: Research Authors: Schnappinger, D. Tags: Tuberculosis PERSPECTIVES Source Type: research